2020 Insurance Packaging 
The Checkup by Singlecare
AUGUST 7, 2025
The generic form of Symbicort is budesonide-formoterol, which was launched in 2020 by the same manufacturer, AstraZeneca. This is called an authorized generic , meaning it is the exact same drug packaged without the brand name. Is there a generic for Symbicort? An authorized generic is usually marketed by the brand-name drug company.
Pharmaceutical Technology
JULY 29, 2025
The drug was first approved by the EMA in September 2020 for use in RA. Jyseleca, a once-daily oral JAK1 preferential inhibitor, is already approved for the treatment of moderate to severe active rheumatoid arthritis (RA) and ulcerative colitis (UC). GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 19, 2025
Both modalities have emerged as the most used platform technologies in developing oligonucleotide-based drugs for CNS disorders since 2020. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51 billion) of these deals. Give your business an edge with our leading industry insights.
Pharmaceutical Commerce
JULY 31, 2025
26 – Eli Lilly and Company announces that it will be constructing four new pharmaceutical manufacturing sites in the United States, representing financial commitments in the expansion space exceeding $50 billion since the start of 2020. It depends on what you're doing.” Subscribe Now!
Pharmaceutical Technology
AUGUST 8, 2025
In 2020, Mylan merged with Upjohn, Pfizer’s off-patent medicine division, to form Viatris. Find out more Mylan has since faced criticism for inflating the price of EpiPen and constraining patient access. The company has faced numerous lawsuits over the years in relation to overcharging drug wholesalers for access.
The Checkup by Singlecare
JULY 3, 2025
The Wegovy package insert says 4% of people taking Wegovy during clinical trials reported anxiety as a side effect. A 2020 study linked dopamine in the midbrain to heightened levels of anxiety, and an earlier MIT study found that a dopamine imbalance caused more paranoid behavior in rats.
Pharmaceutical Technology
JUNE 9, 2025
The European average time between market authorisation and patient access between 2020 and 2024 was defined according to the time (in days) between approval and pricing as well as the time (in days) between approval and reimbursement. These three markets have seen time to reimbursement increase by 83%, 27%, and 32%, respectively, since 2020.
Expert insights. Personalized for you.
Let's personalize your content